Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001723643-25-000003·NEVRO CORP
Schedule 13G ownership disclosure
NEVRO CORP
Common Stock, $0.001 par value per share · CUSIP: 64157F103
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Shay Capital LLC
Shares: 1,571,762.00 · Class: 4.19%
- Shay Capital Holdings LLC
Shares: 1,571,762.00 · Class: 4.19%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001723643-25-000003
- Form type
- SCHEDULE 13G/A
- Filer
- NEVRO CORP
- CIK
- CIK 1444380
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership